Inventor
HYNES JOHN
IE62 patents
⚠️ This page may combine multiple inventors who share the name “HYNES JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
32 patentsUS6670357B2Dec 30, 2003
Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO137 citations95
US6653304B2Nov 25, 2003
Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
BRISTOL MYERS SQUIBB CO62 citations93
US7160883B2Jan 9, 2007
Pyrrolo-triazine aniline compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO23 citations92
US7601844B2Oct 13, 2009
Piperidinyl derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO19 citations91
US10294229B2May 21, 2019
Heteroaryl substituted aminopyridine compounds
BRISTOL MYERS SQUIBB CO9 citations84
US7323482B2Jan 29, 2008
Thiazolyl-based compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO12 citations84
US7169771B2Jan 30, 2007
Thiazolyl-based compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO11 citations84
US9862715B2Jan 9, 2018
Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO5 citations83
US8987311B2Mar 24, 2015
Triazolyl-substituted pyridyl compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO14 citations83
US7759343B2Jul 20, 2010
Pyrrolo-triazine aniline compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO11 citations83
US7034151B2Apr 25, 2006
Process for preparing pyrrolotriazine kinase inhibitors
BRISTOL MYERS SQUIBB CO17 citations82
US12286428B2Apr 29, 2025
Tricyclic heteroaryl compounds useful as IRAK4 inhibitors
BRISTOL MYERS SQUIBB CO2 citations74
US7314876B2Jan 1, 2008
Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO7 citations74
US9242975B2Jan 26, 2016
Heterocyclic-substituted pyridyl compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO4 citations72
US10202390B2Feb 12, 2019
Heteroaryl substituted aminopyridine compounds
BRISTOL MYERS SQUIBB CO3 citations71
US9657009B2May 23, 2017
Heteroaryl substituted pyridyl compounds useful as kinase modulators
BRISTOL MYERS SQUIBB CO4 citations71
US9546153B2Jan 17, 2017
Bicyclic heterocycle substituted pyridyl compounds useful as kinase modulators
BRISTOL MYERS SQUIBB CO5 citations71
US9169252B2Oct 27, 2015
Heteroaryl substituted nicotinamide compounds
BRISTOL MYERS SQUIBB CO5 citations71
US7935696B2May 3, 2011
Heterocyclic amide compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO2 citations63
US7642257B2Jan 5, 2010
Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO2 citations63
US7419978B2Sep 2, 2008
Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO2 citations63
US9242976B2Jan 26, 2016
Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO1 citations62
US7985861B2Jul 26, 2011
Piperidinyl derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO3 citations61
US12304914B2May 20, 2025
Pyrazolo[3,4-d]pyrrolo[1,2-b]pyridazinyl compounds useful as IRAK4 inhibitors
BRISTOL MYERS SQUIBB CO0 citations52
US12304916B2May 20, 2025
Thienopyridinyl and thiazolopyridinyl compounds useful as IRAK4 inhibitors
BRISTOL MYERS SQUIBB CO0 citations52
US10544133B2Jan 28, 2020
Heteroaryl substituted pyridyl compounds useful as kinase modulators
BRISTOL MYERS SQUIBB CO0 citations52
US9221819B2Dec 29, 2015
Spirocyclic compounds as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO0 citations52
US7687508B2Mar 30, 2010
Cyclic derivatives as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO0 citations52
US12492186B2Dec 9, 2025
Bicyclic heterocyclic compounds useful as IRAK4 inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US10227340B2Mar 12, 2019
Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US10023562B2Jul 17, 2018
Heteroaryl substituted pyridyl compounds useful as kinase modulators
BRISTOL MYERS SQUIBB CO0 citations51
US12570659B2Mar 10, 2026
Bicyclic heteroaryl compounds useful as IRAK4 inhibitors
BRISTOL MYERS SQUIBB CO0 citations50
VIAVI SOLUTIONS INC
6 patentsUS10259254B2Apr 16, 2019
Article with a dynamic frame formed with aligned pigment flakes
VIAVI SOLUTIONS INC3 citations84
US10752042B2Aug 25, 2020
Article with dynamic frame formed with aligned pigment flakes
VIAVI SOLUTIONS INC1 citations73
US12466209B2Nov 11, 2025
Article with curved patterns formed of aligned pigment flakes
VIAVI SOLUTIONS INC0 citations62
US11198315B2Dec 14, 2021
Article with curved patterns formed of aligned pigment flakes
VIAVI SOLUTIONS INC0 citations62
US10562333B2Feb 18, 2020
Article with curved patterns formed of aligned pigment flakes
VIAVI SOLUTIONS INC0 citations52
US10232660B2Mar 19, 2019
Article with curved patterns formed of aligned pigment flakes
VIAVI SOLUTIONS INC0 citations52
JDS UNIPHASE CORP
3 patentsUS9102195B2Aug 11, 2015
Article with curved patterns formed of aligned pigment flakes
JDS UNIPHASE CORP39 citations97
US7677462B2Mar 16, 2010
Method of reducing electro-static discharge (ESD) from conductors on insulators
JDS UNIPHASE CORP13 citations76
US7648076B2Jan 19, 2010
Magnetic tape with holographic hidden pattern, method of making same and reader for reading same
JDS UNIPHASE CORP0 citations51
KEYMED MEDICAL & IND EQUIPMENT LTD
3 patents(unassigned)
1 patentSAMTEC INC
1 patentRAIN BASKETBALL INC
1 patentHYNES JOHN
1 patentGARDNER DANIEL S
1 patentHARMONY MEDICAL LTD
1 patentShowing the top 50 of 62 patents by PatentIndex Score.